BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10484058)

  • 1. Beta-cell function during insulin-modified intravenous glucose tolerance test successfully assessed by the C-peptide minimal model.
    Toffolo G; Cefalu WT; Cobelli C
    Metabolism; 1999 Sep; 48(9):1162-6. PubMed ID: 10484058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion.
    Toffolo G; De Grandi F; Cobelli C
    Diabetes; 1995 Jul; 44(7):845-54. PubMed ID: 7789653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between glucose metabolism and endogenous insulin release in hypertension.
    Natalucci S; Boemi M; Fumelli D; Fumelli P; Burattini R
    Metabolism; 2002 Mar; 51(3):297-303. PubMed ID: 11887163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epinephrine exerts opposite effects on peripheral glucose disposal and glucose-stimulated insulin secretion. A stable label intravenous glucose tolerance test minimal model study.
    Avogaro A; Toffolo G; Valerio A; Cobelli C
    Diabetes; 1996 Oct; 45(10):1373-8. PubMed ID: 8826974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian two-compartment and classic single-compartment minimal models: comparison on insulin modified IVGTT and effect of experiment reduction.
    Callegari T; Caumo A; Cobelli C
    IEEE Trans Biomed Eng; 2003 Dec; 50(12):1301-9. PubMed ID: 14656059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods.
    Kjems LL; Vølund A; Madsbad S
    Diabetologia; 2001 Oct; 44(10):1339-48. PubMed ID: 11692185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models.
    Toffolo G; Breda E; Cavaghan MK; Ehrmann DA; Polonsky KS; Cobelli C
    Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E2-10. PubMed ID: 11120653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity.
    Macor C; Ruggeri A; Mazzonetto P; Federspil G; Cobelli C; Vettor R
    Metabolism; 1997 Feb; 46(2):123-9. PubMed ID: 9030815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction.
    Toffolo G; Campioni M; Basu R; Rizza RA; Cobelli C
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E169-E176. PubMed ID: 16144811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of insulin sensitivity and beta-cell function indexes obtained from minimal model analysis of a meal tolerance test.
    Steil GM; Hwu CM; Janowski R; Hariri F; Jinagouda S; Darwin C; Tadros S; Rebrin K; Saad MF
    Diabetes; 2004 May; 53(5):1201-7. PubMed ID: 15111487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog.
    Toffolo G; Bergman RN; Finegood DT; Bowden CR; Cobelli C
    Diabetes; 1980 Dec; 29(12):979-90. PubMed ID: 7002673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling glucose and free fatty acid kinetics during insulin-modified intravenous glucose tolerance test in healthy humans: role of counterregulatory response.
    Thomaseth K; Brehm A; Pavan A; Pacini G; Roden M
    Am J Physiol Regul Integr Comp Physiol; 2014 Aug; 307(3):R321-31. PubMed ID: 24848363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine-induced insulin release in glucokinase-deficient subjects.
    Pueyo ME; Clement K; Vaxillaire M; Passa P; Froguel P; Robert JJ; Velho G
    Diabetes Care; 1994 Sep; 17(9):1015-21. PubMed ID: 7988299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A numerical deconvolution method to estimate C-peptide secretion in humans after an intravenous glucose tolerance test.
    Boston RC; Pei D; Moate PJ
    Metabolism; 2009 Jul; 58(7):891-900. PubMed ID: 19394979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.
    Mari A
    Diabetologia; 1998 Sep; 41(9):1029-39. PubMed ID: 9754821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT.
    Tura A; Kautzky-Willer A; Pacini G
    Diabetes Res Clin Pract; 2006 Jun; 72(3):298-301. PubMed ID: 16325298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Cell function and insulin sensitivity in adolescents from an OGTT.
    Sunehag AL; Man CD; Toffolo G; Haymond MW; Bier DM; Cobelli C
    Obesity (Silver Spring); 2009 Feb; 17(2):233-9. PubMed ID: 19057529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits: a minimal model analysis.
    Zhang B; Saku K; Arakawa K
    Metabolism; 1997 Mar; 46(3):273-81. PubMed ID: 9054469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prehepatic beta-cell secretion during the intravenous glucose tolerance test in humans: application of a combined model of insulin and C-peptide kinetics.
    Watanabe RM; Volund A; Roy S; Bergman RN
    J Clin Endocrinol Metab; 1989 Oct; 69(4):790-7. PubMed ID: 2674187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glucosamine infusion on insulin secretion and insulin action in humans.
    Monauni T; Zenti MG; Cretti A; Daniels MC; Targher G; Caruso B; Caputo M; McClain D; Del Prato S; Giaccari A; Muggeo M; Bonora E; Bonadonna RC
    Diabetes; 2000 Jun; 49(6):926-35. PubMed ID: 10866044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.